Chemicals · Founded 1987 · www.ambaniorganics.com · NSE · ISIN INE00C501018
No Notes Added Yet
Business
Ambani Orgochem Ltd. is an Indian chemicals company primarily engaged in the manufacturing, marketing, and distribution of a range of organic chemical products. Its core business model involves developing and producing various intermediates, specialty chemicals, and potentially some performance chemicals for diverse industrial applications. The company likely employs a B2B sales approach, supplying its products to sectors such as pharmaceuticals, agrochemicals, textiles, automotive, construction, and consumer goods. Ambani Orgochem makes money by selling these manufactured chemicals, leveraging its production capabilities, R&D for product development, and established distribution channels.
Revenue Mix
Specific segments and their contributions are not provided. However, within the organic chemicals sector, Ambani Orgochem Ltd. likely operates in segments such as:
Basic/Bulk Organic Chemicals: High-volume, commodity-type chemicals used as foundational building blocks.
Specialty Organic Chemicals: Lower volume, higher value-added chemicals tailored for specific applications or customer needs, potentially offering better margins.
Intermediates: Chemicals used in the production of other more complex chemicals or finished products.
Performance Chemicals: Organic compounds designed to provide specific functionalities in end products.
Without financial data, the exact revenue mix is unknown, but a diversified portfolio across these segments would be typical for a major player in the "orgochem" space.
Industry
The Indian chemicals industry is diverse, capital-intensive, and subject to global supply-demand dynamics and raw material price volatility. It comprises both fragmented commodity chemical producers and more consolidated specialty chemical manufacturers. India benefits from a growing domestic market and emerging opportunities as a global manufacturing hub ("China Plus One" strategy).
Ambani Orgochem Ltd., given its name implying scale and prominence (common for large Indian conglomerates), is likely positioned as a significant player within the organic chemicals segment. It would compete with both large domestic chemical companies (e.g., Aarti Industries, Vinati Organics) and global chemical majors operating in India. Its positioning could lean towards offering a broad portfolio of organic chemicals or specializing in specific high-growth niches within specialty chemicals, potentially leveraging economies of scale and integrated operations.
MOAT
Scale & Integration: As a potentially large-scale player, Ambani Orgochem could benefit from economies of scale in procurement of raw materials, manufacturing, and distribution, leading to cost efficiencies. Vertical or horizontal integration (e.g., backward integration into key raw materials or forward integration into derivatives) could provide supply chain security and cost advantages.
R&D and Process Innovation: Expertise in organic chemistry, proprietary manufacturing processes, and continuous R&D for new product development or process optimization could create a competitive edge, particularly in specialty chemicals.
Established Customer Relationships: Long-standing relationships with diverse industrial clients across various sectors can lead to sticky demand and repeat business.
Brand Reputation & Trust: A strong corporate brand, associated with quality and reliability (implied by "Ambani"), can be a significant advantage in securing and retaining large industrial clients.
Regulatory Expertise: Ability to navigate India's complex environmental and industrial regulations effectively, ensuring compliant and sustainable operations.
Growth Drivers
Growing Domestic Demand: India's sustained economic growth, urbanization, and expansion of end-user industries (automotive, construction, pharmaceuticals, agrochemicals, textiles) will fuel demand for organic chemicals.
"China Plus One" Strategy: Global manufacturers diversifying their supply chains away from China could lead to increased export opportunities for Indian chemical producers.
New Product Development: Investment in R&D to expand into high-margin specialty chemicals or introduce innovative organic compounds to meet evolving industrial needs.
Infrastructure Development: Government focus on infrastructure projects will drive demand for construction-related chemicals and materials.
Increasing Exports: Leveraging cost competitiveness and quality to penetrate new international markets and increase global market share.
Risks
Raw Material Price Volatility: Dependence on crude oil derivatives or other commodity-based inputs makes the company vulnerable to global price fluctuations, impacting profitability.
Environmental & Regulatory Risks: Increasingly stringent environmental regulations and compliance costs in India could affect operations, require significant capital expenditure, or lead to production constraints.
Global Economic Downturn: A slowdown in global or domestic industrial activity could reduce demand from key end-user sectors, impacting sales and revenue.
Intense Competition: The chemical industry is competitive, leading to potential price wars and pressure on margins from both domestic and international players.
Technological Obsolescence: Failure to continuously innovate or adapt to new production technologies and product demands could lead to loss of market share.
Currency Fluctuations: For companies involved in significant imports of raw materials or exports of finished goods, exchange rate volatility can impact costs and revenues.
Management & Ownership
Ambani Orgochem Ltd. is likely a promoter-driven company, given the "Ambani" name, suggesting strong leadership from an experienced business family or conglomerate. This implies a potentially long-term strategic vision, significant financial backing, and a culture of large-scale execution. The management team would be expected to comprise experienced professionals with deep domain knowledge in the chemicals sector, capable of navigating industry complexities and driving growth. Ownership is typically dominated by the promoter group, with a substantial portion held by institutional investors (domestic and foreign) and the public.
Outlook
Ambani Orgochem Ltd. operates in a critical and growing sector of the Indian economy. The bull case for the company is driven by robust domestic industrial growth, India's increasing role in global chemical supply chains, and the potential for expansion into high-margin specialty chemicals through continuous R&D and strategic investments. Effective cost management, leveraging economies of scale, and strong customer relationships could lead to sustained profitability and market share gains.
Conversely, the bear case highlights significant exposure to volatile raw material prices, the burden of stringent environmental compliance costs, and intense competition which could suppress margins. A slowdown in key end-user industries or adverse global economic conditions could also dampen demand and hinder growth prospects. The company's ability to innovate, manage operational risks, and adapt to evolving market and regulatory landscapes will be crucial for its long-term performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Mar 2021 | Mar 2022 |
|---|---|---|
| Net Sales | 0 | 0 |
| Other Income | 0 | 0 |
| Total Income | 0 | 0 |
| Total Expenditure | 0 | 0 |
| Operating Profit | 0 | 0 |
| Interest | 0 | 0 |
| Depreciation | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 |
| Profit Before Tax | 0 | 0 |
| Provision for Tax | 0 | 0 |
| Profit After Tax | 0 | 0 |
| Adjustments | 0 | 0 |
| Profit After Adjustments | 0 | 0 |
| Adjusted Earnings Per Share | 0 | 0 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 52 | 65 | 80 | 73 | 87 | 125 | 132 | 136 | 193 | 0 |
| Other Income | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| Total Income | 53 | 66 | 80 | 73 | 87 | 126 | 133 | 137 | 194 | 0 |
| Total Expenditure | 49 | 61 | 74 | 68 | 81 | 119 | 124 | 131 | 183 | 0 |
| Operating Profit | 4 | 5 | 6 | 6 | 7 | 7 | 9 | 5 | 11 | 0 |
| Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 8 | 0 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 0 |
| Exceptional Income / Expenses | -0 | 0 | -0 | -0 | 0 | 0 | -0 | 5 | 0 | 0 |
| Profit Before Tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 1 | 1 | 1 | 1 | 1 | -3 | 1 | 0 |
| Profit After Tax | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 | 0 |
| Adjustments | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Profit After Adjustments | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 3 | -1 | 0 |
| Adjusted Earnings Per Share | 0 | 4.6 | 3.4 | 2.7 | 3.3 | 2.7 | 2 | 3.3 | -2 | 0 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 42% | 16% | 21% | 0% |
| Operating Profit CAGR | 120% | 16% | 13% | 0% |
| PAT CAGR | -133% | NAN% | NAN% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -18% | 2% | 5% | NA% |
| ROE Average | -2% | 4% | 6% | 12% |
| ROCE Average | 8% | 7% | 9% | 13% |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 4 | 6 | 15 | 17 | 19 | 36 | 38 | 52 | 57 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 3 | 2 | 2 | 6 | 12 | 24 | 23 | 22 |
| Other Non-Current Liabilities | 5 | 6 | 7 | 9 | 9 | 9 | 9 | 7 | 8 |
| Total Current Liabilities | 26 | 33 | 38 | 35 | 45 | 55 | 67 | 92 | 122 |
| Total Liabilities | 38 | 47 | 61 | 62 | 78 | 112 | 137 | 174 | 208 |
| Fixed Assets | 12 | 13 | 13 | 15 | 21 | 22 | 21 | 59 | 77 |
| Other Non-Current Assets | 0 | 0 | 0 | 2 | 0 | 18 | 49 | 9 | 9 |
| Total Current Assets | 26 | 34 | 48 | 46 | 56 | 72 | 67 | 106 | 123 |
| Total Assets | 38 | 47 | 61 | 62 | 78 | 112 | 137 | 174 | 208 |
| #(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 1 | 3 | 3 | 3 | 11 | 6 | 6 |
| Cash Flow from Operating Activities | 4 | 3 | -2 | 5 | -4 | -0 | 17 | -13 | 11 |
| Cash Flow from Investing Activities | -2 | -2 | -1 | -3 | -6 | -20 | -38 | -1 | 2 |
| Cash Flow from Financing Activities | -2 | -1 | 5 | -2 | 10 | 27 | 16 | 14 | -3 |
| Net Cash Inflow / Outflow | -0 | 0 | 3 | -1 | 1 | 7 | -5 | 0 | 10 |
| Closing Cash & Cash Equivalent | 1 | 1 | 3 | 3 | 3 | 11 | 6 | 6 | 16 |
| # | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.1 | 4.64 | 3.4 | 2.72 | 3.35 | 2.67 | 2.01 | 3.34 | -2.01 |
| CEPS(Rs) | 3.35 | 6.31 | 4.73 | 4.34 | 5.38 | 5.32 | 5.34 | 8.32 | 2.9 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 10.84 | 15.45 | 30.41 | 33.14 | 36.49 | 47.69 | 49.7 | 55.73 | 63.12 |
| Core EBITDA Margin(%) | 6.17 | 6.12 | 5.97 | 6.27 | 6.01 | 4.49 | 5.28 | 3.45 | 4.87 |
| EBIT Margin(%) | 5.93 | 5.67 | 5.34 | 5.74 | 5.73 | 4.24 | 4.78 | 5.2 | 4.29 |
| Pre Tax Margin(%) | 2.25 | 2.79 | 2.58 | 2.7 | 2.66 | 1.96 | 1.99 | 0.19 | 0.22 |
| PAT Margin (%) | 1.53 | 2.33 | 1.86 | 1.63 | 1.73 | 1.41 | 1.31 | 2.24 | -0.44 |
| Cash Profit Margin (%) | 2.44 | 3.18 | 2.58 | 2.6 | 2.78 | 2.39 | 2.27 | 4.31 | 1.15 |
| ROA(%) | 2.12 | 4.15 | 3.17 | 2.23 | 2.43 | 2.12 | 1.59 | 1.95 | -0.45 |
| ROE(%) | 19.37 | 35.28 | 16.19 | 8.57 | 9.63 | 8.17 | 6.31 | 8.54 | -1.95 |
| ROCE(%) | 18.59 | 22.21 | 19.05 | 14.54 | 12.62 | 8.92 | 7.69 | 6.7 | 7.58 |
| Receivable days | 112.21 | 83.1 | 80.33 | 98.88 | 99.34 | 79.23 | 72.61 | 73.52 | 65.54 |
| Inventory Days | 43.84 | 40.18 | 53.93 | 72.52 | 63.85 | 49.92 | 53.51 | 69.89 | 66.78 |
| Payable days | 129.43 | 117.74 | 120.58 | 124.3 | 82.79 | 59.07 | 66.35 | 133.8 | 176.57 |
| PER(x) | 0 | 0 | 19.44 | 22.45 | 13.73 | 41.13 | 40.27 | 30.86 | 0 |
| Price/Book(x) | 0 | 0 | 2.17 | 1.85 | 1.26 | 2.31 | 1.63 | 1.85 | 1.83 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.3 | 0.29 | 0.56 | 0.66 | 0.62 | 0.9 | 0.9 | 0.93 | 0.68 |
| EV/Core EBITDA(x) | 4.15 | 3.88 | 7.49 | 8.31 | 8.2 | 15.12 | 13.6 | 24.56 | 12.15 |
| Net Sales Growth(%) | 0 | 24.71 | 22.08 | -8.58 | 18.93 | 44.22 | 5.64 | 3.15 | 41.36 |
| EBIT Growth(%) | 0 | 38.2 | 15.74 | -2 | 15.58 | 7.74 | 19.11 | -1.92 | 16.63 |
| PAT Growth(%) | 0 | 120.99 | -2.28 | -19.89 | 23.01 | 18.17 | -1.69 | 54 | -128.06 |
| EPS Growth(%) | 0 | 120.99 | -26.68 | -19.89 | 23 | -20.16 | -24.8 | 66.2 | -160.05 |
| Debt/Equity(x) | 3.05 | 2.73 | 0.96 | 1.18 | 1.83 | 1.3 | 1.77 | 1.22 | 1 |
| Current Ratio(x) | 0.98 | 1.04 | 1.27 | 1.31 | 1.26 | 1.3 | 1.01 | 1.15 | 1.01 |
| Quick Ratio(x) | 0.74 | 0.72 | 0.81 | 0.84 | 0.86 | 0.91 | 0.67 | 0.84 | 0.67 |
| Interest Cover(x) | 1.61 | 1.97 | 1.94 | 1.89 | 1.87 | 1.86 | 1.72 | 1.04 | 1.06 |
| Total Debt/Mcap(x) | 0 | 0 | 0.44 | 0.64 | 1.45 | 0.67 | 1.28 | 0.76 | 0.61 |
| # | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.67 | 63.59 | 63.59 | 63.59 | 63.59 | 57.95 | 57.95 | 61.25 | 61.25 | 61.25 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 27.33 | 36.41 | 36.41 | 36.41 | 36.41 | 42.05 | 42.05 | 38.75 | 38.75 | 38.75 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.37 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.47 | 0.47 | 0.47 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.14 | 0.23 | 0.23 | 0.23 | 0.23 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.51 | 0.64 | 0.64 | 0.64 | 0.64 | 0.71 | 0.71 | 0.77 | 0.77 | 0.77 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +42% | +16% | +21% | — |
| Operating Profit CAGR | +120% | +16% | +13% | — |
| PAT CAGR | -133% | 0% | 0% | — |
| Share Price CAGR | -18% | +2% | +5% | — |
| ROE Average | -2% | +4% | +6% | +12% |
| ROCE Average | +8% | +7% | +9% | +13% |
| # | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.67 | 63.59 | 63.59 | 63.59 | 63.59 | 57.95 | 57.95 | 61.25 | 61.25 | 61.25 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 27.33 | 36.41 | 36.41 | 36.41 | 36.41 | 42.05 | 42.05 | 38.75 | 38.75 | 38.75 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.37 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.47 | 0.47 | 0.47 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.14 | 0.23 | 0.23 | 0.23 | 0.23 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.51 | 0.64 | 0.64 | 0.64 | 0.64 | 0.71 | 0.71 | 0.77 | 0.77 | 0.77 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.